Nifty

:

23850.90

Sensex

:

78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Login

Nifty
Sensex

:
:

23850.90
78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Thyrocare Technologies Ltd.

Healthcare Services - Diagnostic

Rating :

N/A

BSE: 539871 | NSE: THYROCARE

Watchlist

NSE BSE

644.50

05-Jul-2024

Open
High
Low
Previous Close

647.35
663.00
640.35
645.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

166613
1081.49
985.00
533.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,169.05
61.56
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,115.12
1.84%
10.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.07
5.66
-0.97

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.68
-4.38
-10.06

PAT CAGR (%)

10 Years
5 Years
3 Years

4.58
-4.24
-26.21

P:E (Median)

8 Years
5 Years
3 Years

39.19
41.18
40.69

P:BV (Average)

8 Years
5 Years
3 Years

8.29
8.60
6.97

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.66
22.66
20.52

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 163.05 136.29 19.63% 143.63 123.61 16.20% 141.23 124.82 13.15% 122.89 117.17 4.88%
Expenses 114.26 99.66 14.65% 101.28 90.49 11.92% 107.64 102.05 5.48% 92.36 91.26 1.21%
EBITDA 48.79 36.63 33.20% 42.35 33.12 27.87% 33.59 22.77 47.52% 30.53 25.91 17.83%
EBIDTM 29.92% 26.88% 29.49% 26.79% 23.78% 18.24% 24.84% 22.11%
Other Income 2.12 1.82 16.48% 3.17 0.46 589.13% 2.81 2.07 35.75% 2.09 1.27 64.57%
Interest 0.63 1.02 -38.24% 0.93 0.80 16.25% 0.94 0.60 56.67% 0.96 0.59 62.71%
Depreciation 9.94 9.30 6.88% 9.45 8.51 11.05% 10.41 9.42 10.51% 10.90 9.01 20.98%
PBT 40.34 28.13 43.41% 35.14 24.27 44.79% 25.05 14.82 69.03% 20.76 17.58 18.09%
Tax 10.75 7.84 37.12% 9.99 7.54 32.49% 5.82 4.89 19.02% 5.87 4.95 18.59%
PAT 29.59 20.29 45.84% 25.15 16.73 50.33% 19.23 9.93 93.66% 14.89 12.63 17.89%
PATM 18.15% 14.89% 17.51% 13.53% 13.62% 7.96% 12.12% 10.78%
EPS 5.58 3.83 45.69% 4.75 3.16 50.32% 3.63 1.87 94.12% 2.81 2.38 18.07%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 177.36 148.00 19.84% 156.91 134.89 16.32% 154.25 135.88 13.52% 134.74 128.03 5.24%
Expenses 129.07 110.48 16.83% 114.27 100.38 13.84% 120.44 111.19 8.32% 103.15 100.17 2.97%
EBITDA 48.29 37.52 28.70% 42.64 34.51 23.56% 33.81 24.69 36.94% 31.59 27.86 13.39%
EBIDTM 27.23% 25.35% 27.17% 25.58% 21.92% 18.17% 23.45% 21.76%
Other Income 2.61 2.17 20.28% 3.62 0.98 269.39% 3.49 3.70 -5.68% 2.73 2.10 30.00%
Interest 0.76 1.13 -32.74% 0.99 0.88 12.50% 1.12 0.67 67.16% 1.07 0.58 84.48%
Depreciation 13.07 10.65 22.72% 11.36 9.83 15.56% 13.06 10.80 20.93% 13.47 10.15 32.71%
PBT 37.07 27.91 32.82% 33.91 24.78 36.84% 23.12 16.92 36.64% 19.78 19.23 2.86%
Tax 10.36 7.94 30.48% 9.61 7.65 25.62% 5.72 4.75 20.42% 5.17 5.02 2.99%
PAT 26.71 19.97 33.75% 24.30 17.13 41.86% 17.40 12.17 42.97% 14.61 14.21 2.81%
PATM 15.06% 13.49% 15.49% 12.70% 11.28% 8.96% 10.84% 11.10%
EPS 5.04 3.84 31.25% 4.56 3.27 39.45% 3.36 2.38 41.18% 2.90 2.78 4.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 570.80 524.02 486.46 561.53 474.27 401.06 370.28 331.79 297.53 235.13 180.08 Net Sales Growth 13.73% 7.72% -13.37% 18.40% 18.25% 8.31% 11.60% 11.51% 26.54% 30.57% Cost Of Goods Sold 171.17 157.59 156.37 165.23 160.55 112.34 105.32 90.85 77.95 66.98 55.23 Gross Profit 399.63 366.43 330.09 396.30 313.72 288.72 264.96 240.94 219.58 168.15 124.85 GP Margin 70.01% 69.93% 67.86% 70.58% 66.15% 71.99% 71.56% 72.62% 73.80% 71.51% 69.33% Total Expenditure 415.54 389.00 372.16 330.00 303.53 233.29 222.14 192.79 182.63 139.99 106.32 Power & Fuel Cost - 7.99 8.56 7.00 6.43 6.33 5.70 4.83 4.65 3.73 3.59 % Of Sales - 1.52% 1.76% 1.25% 1.36% 1.58% 1.54% 1.46% 1.56% 1.59% 1.99% Employee Cost - 102.92 102.61 58.82 56.79 45.75 40.51 32.49 30.22 24.29 16.96 % Of Sales - 19.64% 21.09% 10.47% 11.97% 11.41% 10.94% 9.79% 10.16% 10.33% 9.42% Manufacturing Exp. - 54.18 53.76 10.03 23.19 23.19 5.81 14.12 16.63 14.07 4.08 % Of Sales - 10.34% 11.05% 1.79% 4.89% 5.78% 1.57% 4.26% 5.59% 5.98% 2.27% General & Admin Exp. - 53.22 37.97 73.23 49.56 37.77 60.64 45.42 49.52 30.25 24.88 % Of Sales - 10.16% 7.81% 13.04% 10.45% 9.42% 16.38% 13.69% 16.64% 12.87% 13.82% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 13.10 12.89 15.69 7.01 7.91 4.16 5.08 3.66 0.66 0.00 % Of Sales - 2.50% 2.65% 2.79% 1.48% 1.97% 1.12% 1.53% 1.23% 0.28% 0.88% EBITDA 155.26 135.02 114.30 231.53 170.74 167.77 148.14 139.00 114.90 95.14 73.76 EBITDA Margin 27.20% 25.77% 23.50% 41.23% 36.00% 41.83% 40.01% 41.89% 38.62% 40.46% 40.96% Other Income 10.19 7.18 5.39 7.40 12.28 9.42 13.66 23.63 11.41 5.20 7.70 Interest 3.46 4.88 4.54 3.08 0.66 1.32 0.47 0.40 0.43 0.54 0.29 Depreciation 40.70 39.10 34.08 28.47 21.08 19.54 14.47 12.08 11.69 11.35 10.71 PBT 121.29 98.22 81.07 207.38 161.28 156.33 146.86 150.15 114.18 88.46 70.46 Tax 32.43 27.08 24.10 55.33 41.51 32.68 51.63 51.93 40.08 30.00 23.58 Tax Rate 26.74% 27.57% 29.73% 26.68% 25.74% 29.18% 35.16% 35.10% 46.20% 33.80% 32.64% PAT 88.86 71.14 56.97 152.05 119.77 79.32 95.23 96.03 46.67 58.75 48.66 PAT before Minority Interest 88.86 71.14 56.97 152.05 119.77 79.32 95.23 96.03 46.67 58.75 48.66 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.57% 13.58% 11.71% 27.08% 25.25% 19.78% 25.72% 28.94% 15.69% 24.99% 27.02% PAT Growth 49.14% 24.87% -62.53% 26.95% 51.00% -16.71% -0.83% 105.76% -20.56% 20.74% EPS 16.77 13.42 10.75 28.69 22.60 14.97 17.97 18.12 8.81 11.08 9.18

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 623.26 571.88 526.67 588.86 494.62 434.26 402.91 356.32 304.39 240.97 182.96 Net Sales Growth 13.98% 8.58% -10.56% 19.05% 13.90% 7.78% 13.08% 17.06% 26.32% 31.71% Cost Of Goods Sold 181.44 166.70 163.23 169.69 163.90 117.09 110.53 94.98 81.42 70.35 55.83 Gross Profit 441.82 405.18 363.44 419.17 330.72 317.17 292.38 261.34 222.96 170.61 127.13 GP Margin 70.89% 70.85% 69.01% 71.18% 66.86% 73.04% 72.57% 73.34% 73.25% 70.80% 69.49% Total Expenditure 466.93 433.11 404.14 353.13 323.36 260.69 248.75 211.69 189.03 146.92 110.29 Power & Fuel Cost - 10.15 10.70 8.40 7.64 8.69 7.77 6.68 6.35 5.32 3.95 % Of Sales - 1.77% 2.03% 1.43% 1.54% 2.00% 1.93% 1.87% 2.09% 2.21% 2.16% Employee Cost - 107.86 106.15 61.13 58.07 48.92 43.35 35.34 32.00 25.70 17.48 % Of Sales - 18.86% 20.15% 10.38% 11.74% 11.27% 10.76% 9.92% 10.51% 10.67% 9.55% Manufacturing Exp. - 28.08 19.44 14.72 27.89 27.67 8.29 5.34 6.84 5.81 4.21 % Of Sales - 4.91% 3.69% 2.50% 5.64% 6.37% 2.06% 1.50% 2.25% 2.41% 2.30% General & Admin Exp. - 106.96 91.90 83.69 58.28 49.31 74.33 63.70 58.42 37.60 27.22 % Of Sales - 18.70% 17.45% 14.21% 11.78% 11.35% 18.45% 17.88% 19.19% 15.60% 14.88% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 13.36 12.72 15.50 7.58 9.01 4.48 5.65 3.98 2.13 0.00 % Of Sales - 2.34% 2.42% 2.63% 1.53% 2.07% 1.11% 1.59% 1.31% 0.88% 0.87% EBITDA 156.33 138.77 122.53 235.73 171.26 173.57 154.16 144.63 115.36 94.05 72.67 EBITDA Margin 25.08% 24.27% 23.27% 40.03% 34.62% 39.97% 38.26% 40.59% 37.90% 39.03% 39.72% Other Income 12.45 9.36 8.42 29.25 12.43 6.67 10.13 23.26 12.29 6.54 8.11 Interest 3.94 5.53 4.83 3.21 0.87 1.85 0.61 0.44 0.46 0.55 0.30 Depreciation 50.96 47.01 38.71 33.87 30.28 31.91 26.17 20.10 18.05 18.24 12.87 PBT 113.88 95.59 87.41 227.90 152.54 146.48 137.51 147.35 109.14 81.80 67.62 Tax 30.86 26.49 24.23 51.58 39.32 52.01 52.92 51.71 38.83 30.00 23.58 Tax Rate 27.10% 27.71% 27.72% 22.63% 25.78% 37.18% 38.48% 35.62% 47.52% 36.67% 34.87% PAT 83.02 70.76 64.49 176.14 113.22 87.89 84.59 93.45 42.88 51.80 45.22 PAT before Minority Interest 84.71 69.49 64.36 176.14 113.22 87.89 84.59 93.45 42.88 51.80 44.04 Minority Interest 1.69 1.27 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.18 PAT Margin 13.32% 12.37% 12.24% 29.91% 22.89% 20.24% 20.99% 26.23% 14.09% 21.50% 24.72% PAT Growth 30.78% 9.72% -63.39% 55.57% 28.82% 3.90% -9.48% 117.93% -17.22% 14.55% EPS 15.66 13.35 12.17 33.23 21.36 16.58 15.96 17.63 8.09 9.77 8.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 513.81 521.04 520.70 445.46 378.23 455.78 453.88 417.98 375.38 279.19 Share Capital 52.95 52.93 52.90 52.87 52.84 52.80 53.72 53.72 53.72 50.54 Total Reserves 456.56 463.60 464.37 389.66 321.67 399.10 397.35 359.22 319.07 227.84 Non-Current Liabilities 6.33 138.04 0.43 4.78 1.77 5.93 12.74 10.36 7.33 6.71 Secured Loans 10.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.04 0.00 0.00 Long Term Provisions 2.87 143.73 0.17 13.44 7.88 6.49 5.14 4.34 4.33 1.98 Current Liabilities 75.96 145.88 211.03 62.69 50.75 24.52 18.33 15.78 29.19 6.50 Trade Payables 35.95 22.14 13.41 21.02 19.17 5.37 5.69 0.87 1.46 0.82 Other Current Liabilities 35.97 35.90 38.80 35.75 29.85 17.51 6.52 12.32 8.82 4.09 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.45 0.00 0.00 Short Term Provisions 4.04 87.84 158.82 5.92 1.73 1.64 6.12 2.14 18.92 1.59 Total Liabilities 596.10 804.96 732.16 512.93 430.75 486.23 484.95 444.12 411.90 292.40 Net Block 158.29 155.63 148.31 119.15 111.56 108.26 102.96 89.21 92.58 83.05 Gross Block 300.47 277.56 244.89 192.92 167.12 145.42 125.74 100.90 131.07 109.81 Accumulated Depreciation 142.18 121.93 96.58 73.77 55.56 37.16 22.78 11.69 38.49 26.76 Non Current Assets 350.45 495.76 350.40 330.43 317.10 374.22 347.20 290.47 295.64 192.29 Capital Work in Progress 0.76 0.82 2.15 8.28 3.87 1.28 0.00 2.13 1.36 5.50 Non Current Investment 176.20 172.75 170.34 170.34 170.34 214.67 214.67 194.67 196.29 98.77 Long Term Loans & Adv. 12.91 163.54 23.77 29.06 27.67 49.76 29.34 4.29 5.42 4.99 Other Non Current Assets 1.29 1.98 4.75 3.60 3.66 0.25 0.23 0.16 0.00 0.00 Current Assets 245.65 309.20 381.76 182.50 113.65 112.01 137.75 153.65 116.27 100.11 Current Investments 115.26 101.19 89.05 103.47 69.03 74.64 100.10 104.16 69.49 63.70 Inventories 45.69 27.05 24.22 22.16 18.49 15.56 16.47 13.76 9.89 7.05 Sundry Debtors 40.20 83.31 92.78 44.29 15.19 11.06 8.91 5.98 7.30 4.65 Cash & Bank 34.10 16.39 12.00 7.67 7.30 9.05 9.28 10.62 7.65 4.29 Other Current Assets 10.40 2.94 2.34 2.80 3.64 1.70 2.99 19.13 21.94 20.43 Short Term Loans & Adv. 7.20 78.32 161.37 2.11 2.32 0.65 1.34 14.17 6.62 6.32 Net Current Assets 169.69 163.32 170.73 119.81 62.90 87.49 119.42 137.87 87.07 93.61 Total Assets 596.10 804.96 732.16 512.93 430.75 486.23 484.95 444.12 411.91 292.40

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 526.76 534.30 526.57 427.28 366.65 435.12 443.29 407.81 365.61 276.37 Share Capital 52.95 52.93 52.90 52.87 52.84 52.79 53.72 53.69 53.72 50.54 Total Reserves 469.49 476.84 470.23 371.47 310.08 378.44 386.75 349.08 309.29 225.02 Non-Current Liabilities 10.95 148.69 105.98 17.79 20.51 13.87 10.18 8.61 10.10 8.67 Secured Loans 10.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 2.50 2.50 0.00 7.25 0.00 0.00 Long Term Provisions 3.06 143.86 96.17 13.58 8.16 6.72 5.33 5.15 6.82 3.16 Current Liabilities 90.49 77.09 215.26 95.10 81.69 20.59 20.30 17.62 31.41 7.30 Trade Payables 40.11 23.99 16.53 25.01 21.86 7.51 6.59 1.30 2.02 0.84 Other Current Liabilities 44.45 39.02 39.86 64.13 58.07 11.41 7.51 14.13 10.40 4.82 Short Term Borrowings 1.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 4.10 14.08 158.87 5.96 1.76 1.67 6.20 2.19 18.98 1.65 Total Liabilities 629.06 761.00 847.81 540.17 468.85 469.58 473.77 434.04 407.12 328.35 Net Block 305.88 293.89 284.95 253.06 269.09 294.30 298.75 258.67 259.10 196.01 Gross Block 501.12 461.10 422.59 365.93 359.08 355.40 336.04 276.72 318.18 237.06 Accumulated Depreciation 195.24 167.21 137.64 112.87 89.99 61.10 37.29 18.05 59.07 41.05 Non Current Assets 350.55 488.07 427.05 299.73 316.60 333.56 331.67 284.51 272.71 217.68 Capital Work in Progress 2.55 1.61 2.95 8.28 4.93 1.47 0.00 17.45 1.39 5.55 Non Current Investment 25.62 22.10 20.92 21.10 21.17 20.66 20.00 0.00 1.61 1.61 Long Term Loans & Adv. 15.45 169.40 113.48 14.16 18.32 16.89 12.69 8.23 10.60 14.50 Other Non Current Assets 1.05 1.07 4.75 3.13 3.09 0.24 0.23 0.16 0.00 0.00 Current Assets 278.51 272.93 420.76 240.44 152.25 136.02 142.10 149.53 134.40 110.67 Current Investments 136.75 122.30 125.21 104.49 69.03 74.64 100.10 104.16 91.63 84.30 Inventories 47.52 27.67 24.53 23.36 20.62 18.08 17.05 14.50 10.72 7.37 Sundry Debtors 43.47 85.11 93.20 44.68 16.30 12.16 9.54 6.28 7.50 4.91 Cash & Bank 39.89 28.47 13.91 15.73 11.07 9.60 11.86 11.79 10.29 5.08 Other Current Assets 10.88 3.11 2.44 47.66 35.23 21.54 3.55 12.80 14.26 9.01 Short Term Loans & Adv. 7.49 6.27 161.47 4.52 2.82 1.66 1.87 7.56 6.85 6.61 Net Current Assets 188.02 195.84 205.50 145.34 70.56 115.43 121.80 131.91 103.00 103.37 Total Assets 629.06 761.00 847.81 540.17 468.85 469.58 473.77 434.04 407.11 328.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 155.19 120.02 105.68 111.07 136.33 96.56 111.52 89.28 66.88 36.23 PBT 98.22 81.07 207.38 161.28 156.33 146.86 147.96 86.74 88.76 72.23 Adjustment 63.77 63.40 38.05 14.16 15.76 8.98 0.38 37.76 10.14 2.96 Changes in Working Capital 22.19 4.25 -83.43 -20.78 8.49 2.19 11.17 4.84 -0.87 -16.14 Cash after chg. in Working capital 184.18 148.72 162.00 154.66 180.58 158.03 159.51 129.34 98.03 59.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -28.99 -28.70 -56.32 -43.59 -44.25 -61.47 -47.99 -40.06 -31.15 -22.82 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -80.29 -31.65 -12.32 -53.09 26.84 -3.30 -48.26 -39.66 -18.61 -20.52 Net Fixed Assets -22.85 -31.34 -45.84 -30.21 -24.29 -20.96 -22.71 29.40 -17.12 -21.55 Net Investments -17.52 -14.55 14.42 -34.44 49.94 25.46 -15.94 -33.05 -103.31 -43.47 Others -39.92 14.24 19.10 11.56 1.19 -7.80 -9.61 -36.01 101.82 44.50 Cash from Financing Activity -83.71 -87.50 -86.91 -57.81 -162.65 -96.14 -64.73 -48.50 -44.96 -22.84 Net Cash Inflow / Outflow -8.81 0.87 6.45 0.17 0.52 -2.88 -1.47 1.11 3.31 -7.13 Opening Cash & Equivalents 12.37 11.50 5.05 4.88 4.36 7.24 8.71 7.60 4.29 11.42 Closing Cash & Equivalent 3.56 12.37 11.50 5.05 4.88 4.36 7.24 8.71 7.60 4.29

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 167.63 129.31 113.41 114.73 167.88 100.31 107.03 89.57 67.80 34.46 PBT 95.59 87.41 227.90 152.54 146.48 137.40 144.99 81.67 81.80 67.62 Adjustment 70.87 64.57 21.49 23.05 32.13 24.17 8.78 42.79 17.06 6.50 Changes in Working Capital 30.16 5.79 -79.22 -17.65 33.78 -0.65 2.17 5.57 0.87 -16.86 Cash after chg. in Working capital 196.62 157.77 170.17 157.94 212.39 160.92 155.94 130.03 99.72 57.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -28.99 -28.46 -56.76 -43.21 -44.51 -60.61 -48.91 -40.46 -31.92 -22.79 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -91.28 -38.99 -23.57 -48.66 0.95 -11.59 -43.22 -41.52 -17.68 -17.96 Net Fixed Assets -22.85 -31.34 -45.84 -30.21 -24.29 -20.96 -22.71 29.40 -17.12 Net Investments -17.52 -14.55 14.42 -34.44 49.94 25.46 -15.94 -33.05 -103.31 Others -50.91 6.90 7.85 15.99 -24.70 -16.09 -4.57 -37.87 102.75 Cash from Financing Activity -84.81 -86.18 -89.41 -61.58 -164.78 -93.63 -63.87 -48.52 -44.96 -22.84 Net Cash Inflow / Outflow -8.46 4.14 0.43 4.49 4.05 -4.91 -0.06 -0.46 5.17 -6.34 Opening Cash & Equivalents 17.76 13.63 13.20 8.71 4.91 9.82 9.88 10.35 5.08 11.42 Closing Cash & Equivalent 9.30 17.77 13.63 13.20 8.96 4.91 9.82 9.88 10.24 5.08

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 96.22 97.59 97.78 83.70 70.88 85.59 83.97 76.86 69.39 55.08 ROA 10.16% 7.41% 24.42% 25.38% 17.30% 19.61% 20.67% 10.90% 16.68% 18.08% ROE 13.87% 11.02% 31.68% 29.32% 19.20% 21.09% 22.23% 11.88% 18.05% 20.08% ROCE 19.55% 16.44% 43.57% 39.32% 27.17% 32.39% 33.78% 21.80% 27.28% 28.42% Fixed Asset Turnover 1.81 1.86 2.57 2.63 2.57 2.73 2.93 2.57 1.95 1.83 Receivable days 43.01 66.06 44.55 22.89 11.94 9.84 8.19 8.14 9.27 9.68 Inventory Days 25.33 19.23 15.07 15.64 15.49 15.79 16.63 14.51 13.15 13.52 Payable days 67.27 41.49 38.03 45.68 21.61 11.73 7.76 2.99 3.46 4.69 Cash Conversion Cycle 1.08 43.81 21.59 -7.15 5.83 13.90 17.05 19.66 18.96 18.51 Total Debt/Equity 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 Interest Cover 21.13 18.86 68.33 245.36 85.85 313.47 370.90 201.80 166.59 249.23

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 98.67 100.09 98.89 80.26 68.68 81.69 81.99 75.02 67.57 54.53 ROA 10.00% 8.00% 25.38% 22.44% 18.73% 17.93% 20.59% 10.20% 14.09% 13.41% ROE 13.21% 12.23% 37.18% 28.76% 22.13% 19.41% 22.16% 11.20% 16.22% 15.98% ROCE 18.75% 17.61% 48.42% 38.52% 35.14% 31.36% 33.93% 21.05% 25.66% 24.57% Fixed Asset Turnover 1.19 1.19 1.49 1.36 1.22 1.17 1.16 1.02 0.87 0.77 Receivable days 41.03 61.79 42.73 22.50 11.96 9.83 8.10 8.26 9.40 9.80 Inventory Days 23.99 18.09 14.84 16.23 16.26 15.91 16.16 15.12 13.70 14.70 Payable days 70.18 45.30 44.68 52.19 45.78 13.10 8.88 4.17 4.18 3.23 Cash Conversion Cycle -5.15 34.57 12.90 -13.46 -17.55 12.64 15.38 19.21 18.92 21.27 Total Debt/Equity 0.04 0.00 0.00 0.00 0.01 0.01 0.00 0.02 0.00 0.00 Interest Cover 18.36 19.34 71.94 176.33 76.62 226.43 330.91 177.48 149.46 226.39

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

icici prudential pharma healthcare and diaganostics (p.h.d) fund

quant mutual fund - quant small cap fund

Annual Reports:

News Update:

Thyrocare Tech. - Quarterly Results
23rd Oct 2024, 16:20 PM

Read More
Thyrocare Technologies acquires business of Polo
30th Jul 2024, 10:14 AM

Earlier, the company had executed BTA with Polo to acquire Polo’s diagnostic and pathological services business
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback